Three drugs that have been approved by the Food and Drug Administration (FDA), montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo), block the action of leukotrienes to help prevent and treat the symptoms of asthma. Montelukast has also been approved to relieve symptoms of allergic rhinitis.
Asthma is a chronic lung disease. When asthma strikes, airways in the lungs become inflamed and constricted, causing coughing, wheezing, and difficulty breathing. According to the American Academy of Allergy, Asthma, and Immunology, asthma affects 20 million Americans.
Allergic rhinitis is an allergic response by your immune system to pollens, mold, and dust. It affects about 10% of the population. Symptoms include stuffy, runny, or itchy nose, and sneezing. Children are much more likely to develop allergies if their parents have allergies.
Asthma and allergic rhinitis are both allergic conditions. They can be triggered by many of the same allergens. And, in both conditions, leukotrienes contribute to the development of symptoms. Leukotrienes are hormones that are derived from arachidonate (arachidonic acid) and are produced by white blood cells. They cause inflammation, fluid retention, mucous secretion, and constriction in your lungs.
Montelukast, zafirlukast, and zileuton are all nonsteroidal anti-inflammatory medications and work to prevent symptoms by preventing the action of leukotrienes. Montelukast and zafirlukast work by competitively inhibiting leukotrienes, meaning they compete with leukotrienes in the blood to attach to leukotriene receptors on certain cell surfaces. Zileuton works by stopping the action of an enzyme (5-lipoxygenase), which in turn inhibits leukotriene formation.
Leukotriene receptors are not used to relieve acute symptoms, but can be used for prophylactic or chronic therapy. They also do not block histamines (as do popular antihistamine medications, like Benadryl and Claritin).
The side effects of montelukast, zafirlukast, and zileuton are usually mild and are similar to those reported by patients who were given a placebo. Some of the most common side effects with these drugs are:
Less common side effects include itching, fever, joint pain, muscle aches, and autoimmune reactions.
In deciding whether or not to take a particular medication, the benefits must be weighed against the risks. You and your doctor will decide what’s best for you. For leukotriene receptor agonists, the following ought to be considered:
For more information on medications for asthma or allergies, talk to your doctor.
RESOURCES:
Food and Drug Administration (FDA)
http://www.fda.gov/
National Institute of Allergy and Infectious Diseases
http://www.niaid.nih.gov/
CANADIAN RESOURCES:
Allergy Asthma Information Association
http://aaia.ca/
Health Canada
http://www.hc-sc.gc.ca/index_e.html/
References:
Accolate. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Asthma statistics. American Academy of Allergy Asthma & Immunology website. Available at: http://www.aaaai.org/media/resources/media_kit/asthma_statistics.stm. Accessed May 15, 2009.
Focus on allergy. National Institute of Allergy and Infectious Diseases website. Available at: http://www.niaid.nih.gov/newsroom . Accessed August 7, 2003.
Focus on asthma. National Institute of Allergy and Infectious Diseases website. Available at: http://www.niaid.nih.gov/newsroom . Accessed August 7, 2003.
Montelukast. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Scow DT, Luttermose GK, Dickerson KS. Leukotriene inhibitors in the treatment of allergy and asthma. American Family Physician. 2007;75:65-70.
Singulair. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Zafirlukast. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Zileuton. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Zyflo. Food and Drug Administration website. Available at: http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm . Accessed October 12, 2007.
Last reviewed February 2009 by Shehla Arain, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.